Evidence mapPaperPMID 42450220Full record

ArticleInternational journal of molecular sciences2026

Longstanding Transcriptional Activation of APOA1 and PON1 in Human Hepatocytes by CRISPR/dCas9 Technology: Transcriptomic Profile and Crosstalk with Endothelial Cells.

Jessica I C Haratau, Loredan S Niculescu, Teodora Barbalata, Gabriela M Sanda, Elena V Fuior, Shlomo Sasson, Anca V Sima, Camelia S Stancu, Laura Toma

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jessica I C HaratauLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.
Loredan S NiculescuLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.ORCID 0000-0002-1394-9085
Teodora BarbalataLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.ORCID 0000-0003-1621-4233
Gabriela M SandaLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.
Elena V FuiorGene Regulation and Molecular Therapies Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.ORCID 0000-0001-9166-8417
Shlomo SassonDepartment of Pharmacology, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel.ORCID 0000-0002-9343-526X
Anca V SimaLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.
Camelia S StancuLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.
Laura TomaLipidomics Laboratory, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Haşdeu Street, 050568 Bucharest, Romania.

Funding

EU - PNRR Programme PNRR-III-C9-2022-I8-197Ministry of Education and Research, CCCDI - UEFISCDI PN-IV-P6-6.1-CoEx-2024-0029
6 · The paper itself

Abstract

Apolipoprotein A1 (APOA1) and paraoxonase 1 (PON1) are key proteins of high-density lipoproteins (HDL). The aim of the present study was to obtain and characterize an in vitro model for endogenous APOA1 and PON1 longstanding upregulation in hepatocytes that can be further used to decipher the mechanisms of their protective action. Cultured human hepatocytes (HuH-7 cell line) were transfected with CRISPR/dCas9 activation plasmids targeting

Indexed as

Apolipoprotein A-IAryldialkylphosphataseCRISPR-Cas SystemsHepatocytesTranscriptional ActivationTranscriptomeEndothelial CellsGene Expression ProfilingHumansHuman Umbilical Vein Endothelial CellsOxidative StressTumor Necrosis Factor-alphaAPOA1 protein, humanApolipoprotein A-IAryldialkylphosphatasePON1 protein, humanTumor Necrosis Factor-alphaapolipoprotein A1CRISPR/dCas9hepatocytesin vitro experimental modelparaoxonase 1primary endothelial cellsRNAseqtranscriptomic profile

Identifiers

PMID42450220
PMCPMC13361997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.